Strategies for Transformational Growth

We help life science companies uncover market opportunities, navigate complexity, and accelerate commercial success.
get started
interact to explore

Product Evolution

Market Intelligence

Investment Readiness

Portfolio Strategy

We Tackle Critical Business Questions

SWIPE TO EXPLORE

Product Evolution

  • What does the product need to do to compete?
  • What is the market sentiment for my product?
  • Will it address key market requirements?
  • What is the optimal pricing strategy?
  • How will the reimbursement landscape evolve?
  • What’s the best regulatory path?
  • What is the best go-to-market approach?
Get Started

Market Intelligence

  • What’s the true revenue potential for my product?
  • What is the size and segmentation of the market?
  • Does the model reflect changing market and competitive dynamics?
  • What requirements are critical for entry?
  • How will the technology landscape evolve?
  • Under what assumptions do today’s unmet needs persist?
Get Started

Investment Readiness

FOR INVESTORS

  • What are the characteristics of the optimal targets?
  • Does it do what it claims?
  • Is it significantly better than the status quo?
  • How much work is left?

FOR FOUNDERS

  • How do I maximize our valuation?
  • When am I ready for a raise?
  • How I demonstrate progress?
  • How do I position my company to investors?
Get Started

Portfolio Strategy

  • Should we build, buy, or partner?
  • When should we enter the market?
  • What are the best verticals for investment?
  • Where are the gaps in our existing portfolio?
  • What R&D projects should we advance or sunset?
  • How do I excite my organization around a new class of solution?
Get Started

Product Evolution

  • What does the product need to do to compete?
  • What is the market sentiment for my product?
  • Will it address key market requirements?
  • What is the optimal pricing strategy?
  • How will the reimbursement landscape evolve?
  • What’s the best regulatory path?
  • What is the best go-to-market approach?
Get Started

Market Intelligence

  • What’s the true revenue potential for my product?
  • What is the size and segmentation of the market?
  • Does the model reflect changing market and competitive dynamics?
  • What requirements are critical for entry?
  • How will the technology landscape evolve?
  • Under what assumptions do today’s unmet needs persist?
Get Started

Investment Readiness

FOR INVESTORS

  • What are the characteristics of the optimal targets?
  • Does it do what it claims?
  • Is it significantly better than the status quo?
  • How much work is left?

FOR FOUNDERS

  • How do I maximize our valuation?
  • When am I ready for a raise?
  • How I demonstrate progress?
  • How do I position my company to investors?
Get Started

Portfolio Strategy

  • Should we build, buy, or partner?
  • When should we enter the market?
  • What are the best verticals for investment?
  • Where are the gaps in our existing portfolio?
  • What R&D projects should we advance or sunset?
  • How do I excite my organization around a new class of solution?
Get Started

A History of Transformation

Our clients and their challenges are global. We tackle some of the industry’s toughest scientific and commercial challenges across a broad set of markets and technologies. From pre-funding startups to multinational corporations, the most ambitious teams trust Chrysalis to shape their strategy.
70+
Companies Served
10+
Years of Life Science Strategy
Discover Team

Why We're Different

Industry
Veterans

We've walked in the shoes of our customers, entering new markets and launching industry-changing products. We harness the learnings from decades of successes and failures, bringing clients the confidence to make difficult, high-stakes decisions.

Insiders with
Relationships

Our decades-long relationships with leading scientists, clinicians, and industry executives are personal and collegial, allowing Chrysalis to tap into unfiltered industry knowledge that other firms simply can't.

Actionable
Strategy

We understand the gap between theory and practice. As veteran advisors, we turn complex technology and market insights into best-practices, execution plans, and outcomes-driven strategies.

Hands-On
Approach

We don’t just advise. The founding Chrysalis partners collaborate, build, and roll up our sleeves to drive results with you.

Market Breadth

We help clients navigate healthcare innovation and unlock growth across diagnostics, therapeutics, and digital health.
interact below to explore
CompanionAnimal Testing Agriculture Forensics APPLIEDGENOMICS Lab Automation BiologicsDevelopment Formulation& Delivery Bioprocess Cell & Gene Therapy PHARMA Bioinformatics Genomics Proteomics Imaging / Pathology AssayDevelopment RESEARCH InfectiousDiseaseDiagnostics ReproductiveHealth Point-Of-CareTesting TestingLaboratories CancerDiagnostics HEALTHCARE AI/ Machine Learning Clinical Trials Biomarker Discovery Real World Evidence DIGITAL
Genomics Bioinformatics Proteomics Research Imaging / Pathology AssayDevelopment Lab Automation Biologics Development Bioprocess Formulation & Delivery Cell & Gene Therapy Pharma Infectious Disease Diagnostics Reproductive Health TestingLaboratories CancerDiagnostics Point-Of-CareTesting Healthcare AI / MachineLearning Real WorldEvidence BiomarkerDiscovery Clinical Trials Digital Forensic Agriculture Animal Testing Genomics

Placeholder Title

Click a hexagon... placeholder text

 How We Work with Clients

Our principals stay involved from planning to execution — guiding the process, collaborating closely, and cutting through complexity.

Market Landscape

We define the opportunity: market, competitive, clinical, and customer context — analyzing unmet needs, adjacent spaces, and where innovation fits.

Opportunity Prioritization

We articulate the winning solution, quantify, and prioritize opportunities using market evidence, value drivers, and technical fit.

Strategic Pathways

We draw up the plan: develop tailored strategies aligned to your product, team, and business stage — from product-market fit to scale readiness.

Commercial Roadmap

We build actionable go-to-market plans — defining pricing, messaging, partnerships, and launch sequencing.

Activation & Execution

We identify immediate next steps for the project stakeholders and the organization to move the organization from planning and deliberation to execution and transformation.

Perspective from Our Clients

See how our work has supported commercialization, investment readiness, and product evolution.
"The breadth of the Chrysalis team is unique. They combined exceptional industry expertise with a truly collaborative style. They understood our market challenges immediately and helped us make smarter, more confident decisions, for everything from product strategy to M&A analysis."

Thomas Schweins

SVP Head of Life Science, QIAGEN
“The Chrysalis team is distinguished by its exceptional blend of core foundational understanding and hard-earned, in-the-trenches commercial experience — all of them were in the nucleus of pioneering companies as they commercialized transformational products.”

Matt Posard

Former Global Sales VP, SVP & GM Translational & Consumer Genomics, Illumina
“Many marketing consulting firms claim technical competence; the members of the Chrysalis team demonstrate it.”

Nick Roelofs

Former President, Life Sciences Group, Agilent Technologies
"Working with the Chrysalis team has been a fantastic experience, enabling Broken String to define the optimal commercial strategy for our novel technology platform. For an early-stage startup like ours, Chrysalis' in-depth customer analysis, market and valuation modeling, and pricing guidance was critical for our fundraising as well as our go-to-market planning activities" 

Felix Dobbs

Co-founder & COO, Broken String Biosciences
"Chrysalis brings the rigor, structure, and strategic clarity of a top-tier management consulting organization, but with a depth of genomics and life-science tools expertise that mainstream firms can’t match. They understand the science, the technology, and the market dynamics at a level that allows them to deliver insights that are both strategically sound and scientifically grounded."

Barrett Bready

CEO, Nabsys
"As a European-based prenatal diagnostics company, we engaged Chrysalis to define our strategy for establishing a novel prenatal test in the U.S. market. Chrysalis brought deep expertise across the prenatal diagnostics landscape and quickly clarified a complex environment. Their insights significantly de-risked our evaluation and strengthened future decision-making."

John Riis Mortensen

Chief Operating Officer, Bagger-Sorensen & Co. A/S (owner of ARCEDI Biotech)